Patents by Inventor Patrick John HEXTALL

Patrick John HEXTALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tenascin C antibodies and uses thereof
    Patent number: 11814426
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: November 14, 2023
    Inventors: Kim Suzanne Midwood, Philip Antony Bland-Ward, Nigel Burns, Patrick John Hextall, Susan Rebecca Aungier
  • ANTI-TENASCIN C ANTIBODIES AND USES THEREOF
    Publication number: 20210355201
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Application
    Filed: April 13, 2021
    Publication date: November 18, 2021
    Inventors: Kim Suzanne MIDWOOD, Philip Antony BLAND-WARD, Nigel BURNS, Patrick John HEXTALL, Susan Rebecca AUNGIER
  • Anti-tenascin C antibodies and uses thereof
    Patent number: 11008384
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: May 18, 2021
    Assignee: STERLING IP LIMITED
    Inventors: Kim Suzanne Midwood, Philip Antony Bland-Ward, Nigel Burns, Patrick John Hextall, Susan Rebecca Aungier
  • ANTI-TENASCIN C ANTIBODIES AND USES THEREOF
    Publication number: 20200190177
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Application
    Filed: December 9, 2019
    Publication date: June 18, 2020
    Inventors: Kim Suzanne MIDWOOD, Philip Antony BLAND-WARD, Nigel BURNS, Patrick John HEXTALL, Susan Rebecca AUNGIER
  • Anti-tenascin C antibodies and uses thereof
    Patent number: 10533047
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: January 14, 2020
    Assignee: NASCIENT LIMITED
    Inventors: Kim Suzanne Midwood, Philip Antony Bland-Ward, Nigel Burns, Patrick John Hextall, Susan Rebecca Aungier
  • Tenascin Epitope and Antibodies Thereto
    Publication number: 20190225680
    Abstract: The present disclosure relates to a neutralising epitope for Tenascin-C, and binding domains specific thereto, for example antibodies or binding fragments thereof, pharmaceutical compositions comprising the same and use of said antibodies, binding fragments or composition in treatment, in particular the treatment of an inflammatory disorder.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 25, 2019
    Applicant: Nascient Ltd
    Inventors: Kim Midwood, Eric Culbert, Patrick John Hextall
  • ANTI-TENASCIN C ANTIBODIES AND USES THEREOF
    Publication number: 20190055306
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Application
    Filed: August 17, 2018
    Publication date: February 21, 2019
    Inventors: Kim Suzanne Midwood, Philip Antony Bland-Ward, Nigel Burns, Patrick John Hextall, Susan Rebecca Aungier
  • Anti-tenascin C antibodies and uses thereof
    Patent number: 10093723
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: October 9, 2018
    Assignee: Nascient Limited
    Inventors: Kim Suzanne Midwood, Philip Antony Bland-Ward, Nigel Burns, Patrick John Hextall, Susan Rebecca Aungier
  • ANTI-TENASCIN C ANTIBODIES AND USES THEREOF
    Publication number: 20170306005
    Abstract: There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
    Type: Application
    Filed: August 7, 2015
    Publication date: October 26, 2017
    Inventors: Kim Suzanne MIDWOOD, Philip Antony BLAND-WARD, Nigel BURNS, Patrick John HEXTALL, Susan Rebecca AUNGIER